A 8 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Triticum aestivum L. sprout extract on improvement of Liver function

Woosuk University Korean Medicine Medical Center0 个研究点目标入组 100 人开始时间: 待定最近更新: 2022年5月30日

适应症

试验速览

暂无简介。

•1) Males and females aged 19-70 years at the screening examination
•2) Participants with 46 (U/L)=Alanine Transaminase(ALT)=135 (U/L)
•3) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions.

•1)Patients with a clinically significant disease requiring treatment (i.e., acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
•2)Patients who take medicine for improvement of liver function and intake health functional food within a month prior to the screening examination
•3)Patients with a history of antipsychotic medication use within 3 months prior to the screening examination
•4)Patients who have participated in other clinical trials within 3 months prior to the screening examination
•5)Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes

发起方

Woosuk University Korean Medicine Medical Center